BHUBANESWAR, SEPT 3: The phase-3 clinical trial for India’s first Indigenous dengue vaccine, ‘DengiAll,’ commenced at the Kalinga Institute of Medical Sciences (KIMS) on Tuesday. This trial aims to evaluate
Tag "Phase-3 clinical trial of India’s first dengue vaccine begins at KIMS-Bhubaneswar"
